Evidence map›Paper›PMID 40364465›Full record

ArticleNeurogastroenterology and motility2025

Urogynecologic Symptoms Are Not Specific to Anatomic Region of Digestive Symptoms.

Madison Simons, Tatini Sal-Markar, Debolina Ghosh, Suruchi Ramanujan, Xiao Jing Wang, Yuying Luo

Abstract read
In one paragraph

Article in Neurogastroenterology and motility, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Madison SimonsDigestive Disease Institute, Cleveland Clinic Foundation, Department of Gastroenterology, Hepatology, and Nutrition, Cleveland, Ohio, USA.
Tatini Sal-MarkarCase Western Reserve University School of Medicine, Cleveland, Ohio, USA.
Debolina GhoshCase Western Reserve University School of Medicine, Cleveland, Ohio, USA.
Suruchi RamanujanCase Western Reserve University School of Medicine, Cleveland, Ohio, USA.
Xiao Jing WangDivisions of Gastroenterology and Hepatology, Mayo Clinic, Rochester, USA.ORCID https://orcid.org/0000-0001-7842-1161
Yuying LuoMount Sinai West & Morningside, Mount Sinai Center for Gastrointestinal Physiology and Motility, New York, New York, USA.ORCID https://orcid.org/0000-0003-1738-0313

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND/

aimsMany patients with digestive symptoms describe underlying urinary or gynecologic symptoms, which may increase visceral sensitivity in the abdominopelvic region and amplify distress around digestive symptoms. The aim of this study was to describe the prevalence of urinary and gynecologic symptoms in patients with disorders of gut-brain interaction (DGBI).

methodsConsecutive adult patients with a female reproductive tract who were referred for GI behavioral medicine evaluation for DGBI at a tertiary care center between 2022 and 2023 were prospectively evaluated for symptoms associated with urinary and gynecologic dysfunction. Descriptive statistics were conducted to assess the prevalence of these symptoms within this population by anatomic region affected (esophagus, stomach, and bowel).

resultsA total of 432 patients were included in our cohort with a mean (SD) age of 40.0 years [Q1;Q3 29.0-52.0], with a predominantly White population (86.1%). Dysmenorrhea (61.0%) and menorrhagia (58.6%) were commonly reported among women with digestive symptoms. Urinary symptoms were less common, with 18.7% reporting pain with urination, 33.0% reporting difficulty voiding urine, and 26.1% reporting a history of frequent UTIs. 23% of women experienced ≥ 4 urinary/gynecologic symptoms. There were no significant differences in the type of urogynecologic symptoms reported based on the affected area of the GI tract.

conclusionUrogynecologic symptoms are common among patients with DGBIs affecting the entirety of the GI tract. We presume the presence of these comorbid symptoms is likely to impact symptom severity, quality of life, and could affect treatment response. Future studies are necessary to understand the mechanisms behind these shared conditions as well as develop effective treatments that address their overlap.

Indexed as

Gastrointestinal DiseasesAdultFemaleHumansMiddle AgedPrevalenceProspective StudiesDGBIgendergynecologysexual health

Identifiers

PMID40364465
PMCPMC12534580

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.